Unknown

Dataset Information

0

Approach for Classification and Severity Grading of Long-term and Late-Onset Health Events among Childhood Cancer Survivors in the St. Jude Lifetime Cohort.


ABSTRACT: Characterization of toxicity associated with cancer and its treatment is essential to quantify risk, inform optimization of therapeutic approaches for newly diagnosed patients, and guide health surveillance recommendations for long-term survivors. The NCI Common Terminology Criteria for Adverse Events (CTCAE) provides a common rubric for grading severity of adverse outcomes in cancer patients that is widely used in clinical trials. The CTCAE has also been used to assess late cancer treatment-related morbidity but is not fully representative of the spectrum of events experienced by pediatric and aging adult survivors of childhood cancer. Also, CTCAE characterization does not routinely integrate detailed patient-reported and medical outcomes data available from clinically assessed cohorts. To address these deficiencies, we standardized the severity grading of long-term and late-onset health events applicable to childhood cancer survivors across their lifespan by modifying the existing CTCAE v4.03 criteria and aligning grading rubrics from other sources for chronic conditions not included or optimally addressed in the CTCAE v4.03. This article describes the methods of late toxicity assessment used in the St. Jude Lifetime Cohort Study, a clinically assessed cohort in which data from multiple diagnostic modalities and patient-reported outcomes are ascertained. Cancer Epidemiol Biomarkers Prev; 26(5); 666-74. ©2016 AACR.

SUBMITTER: Hudson MM 

PROVIDER: S-EPMC5413397 | biostudies-literature | 2017 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Approach for Classification and Severity Grading of Long-term and Late-Onset Health Events among Childhood Cancer Survivors in the St. Jude Lifetime Cohort.

Hudson Melissa M MM   Ehrhardt Matthew J MJ   Bhakta Nickhill N   Baassiri Malek M   Eissa Hesham H   Chemaitilly Wassim W   Green Daniel M DM   Mulrooney Daniel A DA   Armstrong Gregory T GT   Brinkman Tara M TM   Klosky James L JL   Krull Kevin R KR   Sabin Noah D ND   Wilson Carmen L CL   Huang I-Chan IC   Bass Johnnie K JK   Hale Karen K   Kaste Sue S   Khan Raja B RB   Srivastava Deo Kumar DK   Yasui Yutaka Y   Joshi Vijaya M VM   Srinivasan Saumini S   Stokes Dennis D   Hoehn Mary Ellen ME   Wilson Matthew M   Ness Kirsten K KK   Robison Leslie L LL  

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20161229 5


Characterization of toxicity associated with cancer and its treatment is essential to quantify risk, inform optimization of therapeutic approaches for newly diagnosed patients, and guide health surveillance recommendations for long-term survivors. The NCI Common Terminology Criteria for Adverse Events (CTCAE) provides a common rubric for grading severity of adverse outcomes in cancer patients that is widely used in clinical trials. The CTCAE has also been used to assess late cancer treatment-rel  ...[more]

Similar Datasets

| S-EPMC8453382 | biostudies-literature
| S-EPMC8633430 | biostudies-literature
| S-EPMC6344300 | biostudies-literature
| S-EPMC8059051 | biostudies-literature
| S-EPMC6679797 | biostudies-literature